Mendelsohn Adam 4
4 · Vivani Medical, Inc. · Filed Aug 31, 2022
Insider Transaction Report
Form 4
Mendelsohn Adam
DirectorChief Executive Officer
Transactions
- Other
Common Stock
2022-08-30+3,622,015→ 3,622,015 total - Other
Common Stock
2022-08-30+90,558→ 90,558 total(indirect: By Trust) - Other
Common Stock Option
2022-08-30+60,373→ 60,373 totalExercise: $3.15From: 2022-08-30Exp: 2028-11-13→ Common Stock (60,373 underlying) - Other
Warrant
2022-08-30+31,774→ 31,774 totalExercise: $3.15From: 2022-08-30Exp: 2023-11-26→ Common Stock (31,774 underlying) - Other
Warrant
2022-08-30+4,585→ 4,585 totalExercise: $3.15From: 2022-08-30Exp: 2023-12-14→ Common Stock (4,585 underlying)
Footnotes (5)
- [F1]Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical Inc. consummated August 30, 2022.
- [F2]Represents shares of common stock held by three trusts for the benefit of the children of the Reporting Person, over which the Reporting Person and his spouse have joint voting and diapositive authority. The Reporting Person disclaims pecuniary ownership in the shares of common stock held by the three trusts. Excludes 77,331 shares of common stock held by MFE, LLC in which the Reporting Person has a 10% ownership interest and therefore a pecuniary interest in such shares, but over which the Reporting Person does not have any voting or diapositive authority.
- [F3]Represents the replacement option to be issued by Vivani Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022.
- [F4]The option vests 1/48 per month over the four years after the date of grant commencing on December 12, 2018, and the balance thereafter vests in full on the fifth anniversary of the date of grant.
- [F5]Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision Medical, Inc., consummated on August 30, 2022 pursuant to the Agreement and Plan of Merger dated February 4, 2022.